SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-011738
Filing Date
2021-06-07
Accepted
2021-06-07 16:34:04
Documents
15
Period of Report
2021-06-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xfor-20210607.htm   iXBRL 8-K 51528
2 EX-10.1 ex10106072021.htm EX-10.1 14693
6 image_0.jpg GRAPHIC 6219
7 image_1.jpg GRAPHIC 1190
  Complete submission text file 0001628280-21-011738.txt   227395

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20210607.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20210607_lab.xml EX-101.LAB 25998
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20210607_pre.xml EX-101.PRE 13731
8 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20210607_htm.xml XML 11812
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 21999942
SIC: 2836 Biological Products, (No Diagnostic Substances)